WO2005020862A8 - Crosslinking reagent for treating vertebral disc disorders - Google Patents
Crosslinking reagent for treating vertebral disc disordersInfo
- Publication number
- WO2005020862A8 WO2005020862A8 PCT/US2004/028039 US2004028039W WO2005020862A8 WO 2005020862 A8 WO2005020862 A8 WO 2005020862A8 US 2004028039 W US2004028039 W US 2004028039W WO 2005020862 A8 WO2005020862 A8 WO 2005020862A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- increasing
- intervertebral disc
- tissue
- crosslinking reagent
- crosslinking
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004268628A AU2004268628B2 (en) | 2001-08-31 | 2004-08-27 | Crosslinking reagents for treating intervertebral disc disorders |
KR1020067004202A KR101238647B1 (en) | 2003-08-28 | 2004-08-27 | Crosslinking reagents for treating intervertebral disc disorders |
CA2536415A CA2536415C (en) | 2001-08-31 | 2004-08-27 | Crosslinking reagent for treating intervertebral disc disorders |
JP2006524909A JP4955388B2 (en) | 2001-08-31 | 2004-08-27 | Cross-linking reagent for treating spinal disc disease |
EP04782506.2A EP1660001B1 (en) | 2001-08-31 | 2004-08-27 | Crosslinking reagent for treating vertebral disc disorders |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31628701P | 2001-08-31 | 2001-08-31 | |
US10/230,671 US9084772B2 (en) | 2001-08-31 | 2002-08-29 | Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues |
US49879003P | 2003-08-28 | 2003-08-28 | |
US60/498,790 | 2003-08-28 | ||
US10/786,861 US7435722B2 (en) | 2001-08-31 | 2004-02-24 | Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability |
US10/786,861 | 2004-02-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005020862A1 WO2005020862A1 (en) | 2005-03-10 |
WO2005020862A8 true WO2005020862A8 (en) | 2005-05-19 |
Family
ID=46205331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/028039 WO2005020862A1 (en) | 2001-08-31 | 2004-08-27 | Crosslinking reagent for treating vertebral disc disorders |
Country Status (7)
Country | Link |
---|---|
US (1) | US8450276B2 (en) |
EP (1) | EP1660001B1 (en) |
JP (1) | JP4955388B2 (en) |
AU (1) | AU2004268628B2 (en) |
CA (1) | CA2536415C (en) |
TW (1) | TW200526203A (en) |
WO (1) | WO2005020862A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070202143A1 (en) * | 2001-08-31 | 2007-08-30 | Hedman Thomas P | Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints |
US8119599B2 (en) * | 2001-08-31 | 2012-02-21 | Orthopeutics, L.P. | Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
WO2012006095A1 (en) | 2010-06-28 | 2012-01-12 | Hedman Thomas P | Tissue crosslinking for treatment of snoring and obstructive sleep apnea |
JP2009525327A (en) * | 2006-02-02 | 2009-07-09 | ヘドマン,トム | Direct application of non-toxic cross-linking reagents that resist progressive spinal deformities |
US10278947B2 (en) | 2007-02-28 | 2019-05-07 | Orthopeutics, L.P. | Crosslinker enhanced repair of connective tissues |
SE1550338A1 (en) * | 2015-03-20 | 2016-09-21 | Stayble Therapeutics Ab | A composition for use in the treatment of intervertebral misalignment |
US11951231B2 (en) * | 2018-01-31 | 2024-04-09 | Kinki University | Therapeutic agent for intervertebral disc degeneration and material for culturing inter vertebral disc cells |
CN113545337B (en) * | 2021-07-21 | 2022-08-26 | 益诺思生物技术南通有限公司 | Method for sizing a mammalian heart valve |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5108438A (en) | 1989-03-02 | 1992-04-28 | Regen Corporation | Prosthetic intervertebral disc |
US5270446A (en) | 1989-04-04 | 1993-12-14 | Suntory Limited | Decolorized crosslinked products and method for decolorization of crosslinked products |
FR2692582B1 (en) | 1992-06-18 | 1998-09-18 | Flamel Tech Sa | NEW CROSSLINKABLE DERIVATIVES OF COLLAGEN, THEIR PROCESS FOR OBTAINING IT AND THEIR APPLICATION TO THE PREPARATION OF BIOMATERIALS. |
JPH0725761A (en) | 1993-07-09 | 1995-01-27 | Kureha Chem Ind Co Ltd | Agent for protecting cartilage |
EP0713707A1 (en) | 1994-11-23 | 1996-05-29 | Collagen Corporation | In situ crosslinkable, injectable collagen composition for tissue augmention |
US5865849A (en) | 1995-06-07 | 1999-02-02 | Crosscart, Inc. | Meniscal heterografts |
US5916573A (en) | 1995-08-21 | 1999-06-29 | Spiers; Samantha M. | Topical treatment of the skin with a grapeseed oil composition |
EP0941130B1 (en) | 1996-11-05 | 2003-03-26 | Challenge Bioproducts Co., Ltd. | Chemical modification of biomedical materials with genipin |
WO1998055533A1 (en) | 1997-06-04 | 1998-12-10 | Biocompatibles Limited | Zwitterionic compounds and their use to cross-link collagenous materials |
US6080579A (en) * | 1997-11-26 | 2000-06-27 | Charlotte-Mecklenburg Hospital Authority | Method for producing human intervertebral disc cells |
US20010006948A1 (en) * | 1998-11-25 | 2001-07-05 | James D. Kang | Gene transfer to intervertebral disc cells |
US6534086B1 (en) | 2000-03-06 | 2003-03-18 | Metagenics, Inc. | Composition and method for treatment of inflammation and pain in mammals |
US6428576B1 (en) * | 1999-04-16 | 2002-08-06 | Endospine, Ltd. | System for repairing inter-vertebral discs |
US6719797B1 (en) * | 1999-08-13 | 2004-04-13 | Bret A. Ferree | Nucleus augmentation with in situ formed hydrogels |
US9314339B2 (en) | 2000-03-27 | 2016-04-19 | Formae, Inc. | Implants for replacing cartilage, with negatively-charged hydrogel surfaces and flexible matrix reinforcement |
US6723335B1 (en) * | 2000-04-07 | 2004-04-20 | Jeffrey William Moehlenbruck | Methods and compositions for treating intervertebral disc degeneration |
US6620798B1 (en) | 2000-06-06 | 2003-09-16 | Russell Jaffe | Synergistic agents for enhancing tissue repair |
US6439238B1 (en) | 2000-06-30 | 2002-08-27 | Pi Medical, Inc. | Snoring diagnostic and treatment |
WO2003002003A2 (en) * | 2001-06-29 | 2003-01-09 | The Trustees Of Columbia University | Optical transesophageal echocardiography probe |
US7435722B2 (en) * | 2001-08-31 | 2008-10-14 | University Of Southern California | Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability |
US8022101B2 (en) * | 2001-08-31 | 2011-09-20 | Orthopeutics, L.P. | Method of treating a knee meniscus with a cross-linking reagent to increase resistance to tearing or rupturing |
CN1578624A (en) * | 2001-08-31 | 2005-02-09 | 南加利福尼亚大学 | Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability |
US8153600B2 (en) * | 2001-08-31 | 2012-04-10 | Orthopeutics, L.P. | Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity |
US8119599B2 (en) * | 2001-08-31 | 2012-02-21 | Orthopeutics, L.P. | Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
MXPA04005707A (en) * | 2001-12-10 | 2005-06-20 | Colbar Lifescience Ltd D | Methods, devices, and preparations for intervertebral disc treatment. |
US6812211B2 (en) * | 2002-03-19 | 2004-11-02 | Michael Andrew Slivka | Method for nonsurgical treatment of the intervertebral disc and kit therefor |
US7208171B2 (en) | 2002-10-31 | 2007-04-24 | Northwestern University | Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
US7157428B2 (en) | 2003-11-26 | 2007-01-02 | Histogenics, Corp. | Method for treatment and repair of meniscal injuries |
US8283322B2 (en) * | 2008-08-15 | 2012-10-09 | Orthopeutics, Lp | Formulations for nonsurgical exogenous crosslink therapy |
US20100040593A1 (en) * | 2008-08-15 | 2010-02-18 | Orthopeutics, Lp | Formulations for nonsurgical exogenous crosslink therapy |
US8198248B2 (en) * | 2008-08-15 | 2012-06-12 | Orthopeutics, Lp | Formulations for nonsurgical exogenous crosslink therapy |
-
2004
- 2004-08-27 AU AU2004268628A patent/AU2004268628B2/en active Active
- 2004-08-27 EP EP04782506.2A patent/EP1660001B1/en active Active
- 2004-08-27 TW TW093125979A patent/TW200526203A/en unknown
- 2004-08-27 WO PCT/US2004/028039 patent/WO2005020862A1/en active Application Filing
- 2004-08-27 CA CA2536415A patent/CA2536415C/en active Active
- 2004-08-27 JP JP2006524909A patent/JP4955388B2/en active Active
-
2010
- 2010-06-16 US US12/816,674 patent/US8450276B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1660001B1 (en) | 2019-10-09 |
AU2004268628B2 (en) | 2009-11-12 |
JP2007504162A (en) | 2007-03-01 |
US8450276B2 (en) | 2013-05-28 |
TW200526203A (en) | 2005-08-16 |
US20100266544A1 (en) | 2010-10-21 |
EP1660001A4 (en) | 2010-12-15 |
JP4955388B2 (en) | 2012-06-20 |
EP1660001A1 (en) | 2006-05-31 |
CA2536415A1 (en) | 2005-03-10 |
AU2004268628A1 (en) | 2005-03-10 |
CA2536415C (en) | 2013-07-23 |
WO2005020862A1 (en) | 2005-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1521083A3 (en) | Method for diagnosing and distinguishing stroke | |
WO2003027248A8 (en) | Antibody inhibitors of gdf-8 and uses thereof | |
CA2437575A1 (en) | Method and device for treating abnormal curvature of the spine | |
WO2005011522A3 (en) | Prosthetic spinal disc replacement | |
WO2001036977A8 (en) | Identification of disease markers involving mass-based-separation | |
WO2002102277A3 (en) | Prosthetic graft assembly and method of use | |
WO2005020862A8 (en) | Crosslinking reagent for treating vertebral disc disorders | |
CY1107640T1 (en) | METHOD FOR CERTIFICATING FACTORS FOR DIABETES TREATMENT | |
WO2004026161A8 (en) | Low profile instrument immobilizer | |
WO2000018954A3 (en) | Use of pex in the treatment of metabolic bone diseases | |
WO2007089233A8 (en) | Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity | |
WO1997023611A3 (en) | Nucleic acid sequences of genes of the high mobility group proteins and uses thereof | |
WO1999049038A3 (en) | Human calcium-binding proteins | |
WO2006002016A3 (en) | Medical systems for the spine and related methods | |
WO2003008553A3 (en) | Proteins associated with cell growth, differentiation, and death | |
WO2000044900A3 (en) | Nucleic-acid binding proteins | |
WO2003014322A3 (en) | Proteins associated with cell growth, differentiation, and death | |
WO2003000844A3 (en) | Protein modification and maintenance molecules | |
GB9312315D0 (en) | Leukocyte adhesion assay | |
CA2366523A1 (en) | Method for analyzing the amount of intraabdominal adipose tissue | |
WO1999031128A3 (en) | Human tumor necrosis factor-r2-like proteins | |
EP2202241A3 (en) | Therapeutic compounds and methods for modulating V3, a versican isoform | |
WO2001083754A3 (en) | Cellular regulators of infectious agents and methods of use | |
WO2001083524A3 (en) | Rna metabolism proteins | |
WO2002014536A3 (en) | Odulating multiple lineage kinase proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page |
Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE |
|
ENP | Entry into the national phase |
Ref document number: 2536415 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004782506 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067004202 Country of ref document: KR Ref document number: 2006524909 Country of ref document: JP Ref document number: 2004268628 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2004268628 Country of ref document: AU Date of ref document: 20040827 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004268628 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004782506 Country of ref document: EP |